# FEBUXOSTAT
> **ANDA210741** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2023-10-25
## Drug
- **FDA Application Number:** ANDA210741
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FEBUXOSTAT
- **Generic name:** FEBUXOSTAT
- **Active ingredients:** FEBUXOSTAT
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AUROBINDO PHARMA LTD
- **Manufacturer:** Aurobindo Pharma Limited
- **First approval:** 2023-10-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210741)
---
*AI Analytics · CC0 1.0*